Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

201
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
201
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

251
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
251
Cancer Survival Analysis01:21

Cancer Survival Analysis

357
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
357
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

136
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
136
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

450
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
450
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

154
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
154

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low serum selenium combined with SELENOP-autoantibodies are associated with persistent fatigue after SARS-CoV-2 infection.

Redox biology·2026
Same author

Ascertainment of Cancer Cases in the German National Cohort (NAKO): Methods and Initial Results.

Deutsches Arzteblatt international·2026
Same author

Ethical perceptions of DRG-based hospital financing among physicians and hospital managers in Germany: a cross-sectional survey.

BMC medical ethics·2026
Same author

Salvage Radiotherapy Confers an Overall Survival Advantage in Biochemical Recurrence of Prostate Cancer: Evidence from the International PROMISE Registry.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

Reassessing the incidence of uveal melanoma in Germany: Insights from current cancer registry data.

Cancer epidemiology·2026
Same author

Self-rated health and mental health before and during the early phase of the COVID-19 pandemic in Germany: the population-based German National Cohort (NAKO) study.

BMC public health·2026

Related Experiment Video

Updated: Jul 12, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K

Distance-Metric Learning for Personalized Survival Analysis.

Wolfgang Galetzka1, Bernd Kowall1, Cynthia Jusi2

  • 1Institute of Medical Informatics, Biometrics and Epidemiology, University Hospital Essen, 45130 Essen, Germany.

Entropy (Basel, Switzerland)
|October 28, 2023
PubMed
Summary

This study introduces a new interpretable survival prediction model using weighted nearest neighbors. It offers personalized predictions with explanations, outperforming existing methods on breast cancer data.

Keywords:
kernel regressionmachine learningmetric learningpersonalized medicinesurvival analysis

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

296

Related Experiment Videos

Last Updated: Jul 12, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

296

Area of Science:

  • Biostatistics
  • Machine Learning
  • Medical Informatics

Background:

  • Accurate time-to-event prediction is crucial in healthcare, especially with right-censored data.
  • Current machine learning models (e.g., random survival forests, neural networks) lack interpretability for survival predictions.
  • There is a need for interpretable methods in personalized survival analysis.

Purpose of the Study:

  • To propose a novel, interpretable method for personalized survival prediction using weighted nearest neighbors.
  • To develop a model that provides explanations for individual predictions by identifying influential data points.
  • To evaluate the proposed method's performance against established survival prediction techniques.

Main Methods:

  • A weighted nearest neighbors approach is proposed for survival prediction.
  • Model fitting involves optimizing weights by learning an appropriate metric.
  • Interpretability is achieved by presenting influential data points and their associated weights for each prediction.

Main Results:

  • The weighted nearest neighbors method demonstrates competitive predictive performance.
  • Strengths and weaknesses were analyzed using simulated data.
  • The method was successfully applied to two real-world breast cancer patient datasets.

Conclusions:

  • The proposed weighted nearest neighbors method offers an interpretable alternative for survival prediction.
  • This approach enhances transparency in personalized risk assessment for time-to-event data.
  • The method shows promise for clinical applications, particularly in oncology.